CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.

assignment_turned_inproject

Funder: Institut National du CancerProject code: INCa-DGOS-3761 Call for proposal: PHRC11

Funded under: PHRC

CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.

- Summary
- DMPs

Partners

Hôpital Purpan , Hôpital de la Conception , Institut Gustave Roussy , Centre Léon Bérard , Hôpital Roger Salengro , Hôpital Bretonneau , Institut de Cancérologie de Lorraine , ICM-VAL D'AURELLE , Centre Hospitalier Universitaire de la Réunion , CHU Marseille - Hôpital la Timone

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::60ba2a7637400371611b6b0e6ae7f0fb&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.

CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.

Loading